Psilocybin induces stereotyped movements and reduces defensive responding in planarians through 5-hydroxytryptamine mechanisms

Behavioural Pharmacology · Published 2026-05-26 · DOI 10.1097/fbp.0000000000000879

Authors (7)

Razeen J. Akbar, Amy D. Stringer, Sonita Wiah, Meghana Dachepalli, Stephanie E. Daws, Saadet Inan, Scott M. Rawls

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Akbar, R., Stringer, A., Wiah, S., et al. (2026). Psilocybin induces stereotyped movements and reduces defensive responding in planarians through 5-hydroxytryptamine mechanisms. Behavioural Pharmacology. https://doi.org/10.1097/fbp.0000000000000879

Related articles

• Parsing the hypophagic and anxiogenic effects of cocaine in male and female rats · Behavioural Pharmacology · 2025 · Same journal
• Investigation of p-coumaric acid on intracerebroventricular lipopolysaccharide-induced spatial memory impairment and neuroinflammation in rats · Behavioural Pharmacology · 2025 · Same journal
• Comparison of the hot-plate pain effect between three inhalation methods and subcutaneous injection of heroin · Behavioural Pharmacology · 2025 · Same journal
• The 5-HT7 receptor antagonist SB-656104A fails to affect breakpoints for cocaine self-administration in male rats · Behavioural Pharmacology · 2026 · Same journal
• Delta opioid receptors on parvalbumin cells are necessary for the convulsant and anxiolytic effects of the delta agonist SNC80 · Behavioural Pharmacology · 2026 · Same journal
• Sex-dependent analgesic effects of phoenixin-14 on mechanical allodynia in mouse models of neuropathic and inflammatory pain · Behavioural Pharmacology · 2026 · Same journal
• Limited effects of zolmitriptan maintenance on the pharmacodynamic profile of intravenous cocaine in humans · Behavioural Pharmacology · 2025 · Same journal
• N-acetylcysteine: a promising strategy for alleviating damages induced by maternal deprivation in neonatal rats · Behavioural Pharmacology · 2026 · Same journal
• A review on the validity of animal models for neuropsychiatric disorders: an exploration of anhedonia · Behavioural Pharmacology · 2025 · Same journal
• Wortmannin, a potent phosphatidylinositol 3-kinase inhibitor, suppresses methamphetamine-induced stereotypy and hyperlocomotion in mice · Behavioural Pharmacology · 2026 · Same journal